Tue, Jul 22, 2014, 9:37 AM EDT - U.S. Markets close in 6 hrs 23 mins

Recent

% | $
Click the to save as a favorite.

Joy Global, Inc. Message Board

js291955 433 posts  |  Last Activity: Jul 14, 2014 10:58 AM Member since: May 31, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • js291955 js291955 Jul 14, 2014 10:58 AM Flag

    In addition, Morgan Stanley analyst Thomas Whitehead reiterated an Overweight rating and $15.00 price target on June 19th. I think this slide was technical in the sense that selling pressure under $12 triggered multiple sell stops. Now, everyone is left wondering what happened and when they realize that nothing really changed, we'll be back above $12.20 this week. Bought more at 11.43 so I'm taking advantage of the panic.

    Sentiment: Buy

  • js291955 js291955 Jul 14, 2014 7:45 AM Flag

    Looks like we hit millions of shares of stops on the way down. Then some bargain hunting. What's going to happen today? Guess I'm talking to myself!

    Sentiment: Buy

  • On April 30th, 10 million shares of SYNA were short. Yesterday we traded a little more than 3 million shares. Hmm, I guess that leaves at least 7 million shares short in the hands of fools. Fuel for the rocket!

    Sentiment: Strong Buy

  • until 100

    Sentiment: Strong Buy

  • From Digitimes:

    Shipments of smartphones in the China market declined 6.4% sequentially in the first quarter of 2014 as consumers delayed plans for the purchase of new phones or replacements, given that handset vendors have postponed the release of sub-CNY1,000 (US$160) 4G models to the second quarter due to a high inventory levels of 3G smartphones, according to Digitimes Research.

    Samsung Electronics ranked the top smartphone vendor in China in terms of shipment volume in the first quarter of 2014, followed by Apple, Xiaomi Technology and Coolpad, said Digitimes Research.

    However, the popularity of the sub-CNY1,000 4G models did not pick up significantly in the first quarter of 2014 since the availability of 4G chipset solutions supporting 10 band, 5-mode standards is limited to only Qualcomm and Marvell Technology. 4G smartphones built with Qualcomm's solutions are priced CNY1,500-2,000, while those built using Marvell's can be available for less than CNY1,000. Coolpad was the only vendor that adopts Marvell's 4G solutions in the first quarter of 2014.

    China Mobile has a total of 770 million mobile service subscribers, accounting for over 60% of China's mobile service market, making the carrier a major force to push 4G services in China. Initially, users looking for 4G are more likely to buy high-end smartphones from international brands. Apple, which began to promote its 4G-enabled iPhones in China in cooperation with China Mobile in mid-January 2014, thus became the biggest winner in the race for 4G smartphone sales in China in the first quarter.

    With handset vendors expected to complete their transition from 3G to 4G and clear-out 3G inventories, plus the release of 4G solutions by MediaTek in the second quarter of 2014, China-based vendors will be eager to launch sub-CNY1,000 4G smartphones starting in the quarter, accelerating the expansion of the 4G subscriber base for China Mobile.

  • js291955 js291955 May 1, 2014 10:50 AM Flag

    Oh I almost forgot. After they drive it down, we buy as much as we can afford to profit from the inevitable post manipulation rally.

    Sentiment: Buy

  • to dump SYNA no matter how good their earnngs are or how good the guidance is because the market manipulators will drive SYNA down to help the shorts and maximaize their profits.

    Can you all help me remember this?

    Sentiment: Buy

  • js291955 js291955 May 1, 2014 4:05 AM Flag

    The second paragraph of what you posted is old news from 2013. Lemtrada is not on Fast Track now.

    "Alemtuzumab has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). The FDA's Fast Track program is designed to expedite the review of new drugs that are intended to treat serious or life-threatening conditions and demonstrate the potential to address unmet medical needs. Under Fast Track designation, alemtuzumab for MS is eligible for Priority Review."

  • js291955 by js291955 Apr 29, 2014 7:00 AM Flag

    "Operating profit at Samsung's (OTC:SSNLF) mobile division fell 1.2% to 6.43T won ($6.2B) but surpassed expectations, with the company shipping 113M phones and tablets. Samsung forecast that profits will rally in Q2 and beyond, helped by strong sales of its new Galaxy S5 flagship device."

    With Synaptics components, of course.

    Sentiment: Strong Buy

  • Reply to

    Down, really?

    by ydkwia33 Apr 28, 2014 10:03 AM
    js291955 js291955 Apr 28, 2014 11:35 AM Flag

    Same pattern of manipulation as yesterday. I think we have some high speed traders manipulating this stock. Float is small so it's easy to do. They'll load up at 60 or below and sail into earnings in July with huge profits. Then another quarter of manipulation.

  • js291955 by js291955 Apr 25, 2014 11:59 PM Flag

    The most manipulted stock on Wall Street.

  • js291955 js291955 Apr 25, 2014 10:51 AM Flag

    FY2015 EPS estimates are currently $4.32/share. FY2015 starts in June 2014. With the new revenue targets for the June 2014 quarter being raised substantially, the current forward P/E of 15.5 will come down significantly and for a growth stock growing at 30-40% per year, SYNA is very cheap.

  • Reply to

    bottom line

    by buck409 Apr 8, 2014 2:59 AM
    js291955 js291955 Apr 8, 2014 5:00 AM Flag

    JRCC will eventually go to zero and shareholders will be wiped out. This was obviously going to happen so which fools bought it at 70 cents?

    Sentiment: Strong Sell

  • Analysts are becoming increasingly confident that touchpad sensor developer Synaptics (SYNA) won the fingerprint sensor design slot for the Samsung's Galaxy S smartphone.

    Analyst Jeffery Schreiner with Feltl & Co. wrote in a March 15 report that the deal could be Synaptics' largest outside of Apple (AAPL). This suggests "SYNA hit a grand slam in its first at bat in the (fingerprint sensor) market," Schreiner said.

    While still speculation on the part of analysts, Robert Stone with Cowen & Co. was confident enough in his research to raise his price target on the stock to 80 from 70. Schreiner's price target went to 70 from 67.

    Synaptics' original strength was touchpads used in notebook computers, but analysts see the company as a rising pure play on the fast-growing fingerprint sensor market. Fingerprint sensors secure devices by "reading" fingerprints and unlocking a device only for authorized users.

    IDC/Gartner estimates the market, not including Apple, will surge from 30 million devices in 2013 to 530 million by 2016. And an increasing number of those devices will be in smartphones and mobile devices, whereas notebook computers had previously shown the strongest use of the technology.

    "We believe due to the shift toward mobile, (2014) represents the first of a multi-inning growth opportunity within FP sensors," Schreiner wrote.

    Sentiment: Strong Buy

  • Reply to

    March 25th

    by grandmaster2986 Mar 25, 2014 1:43 PM
    js291955 js291955 Mar 30, 2014 10:16 PM Flag

    Yes, there will be a lot of volatility after the sales numbers come out. Should be interesting. There's no volatility now because there's no data to trade on. Everyone's in the dark.

  • Reply to

    March 25th

    by grandmaster2986 Mar 25, 2014 1:43 PM
    js291955 js291955 Mar 28, 2014 9:19 AM Flag

    Yes, they are legally required to report Lemtrada sales at the end of each quarter. It's part of the contract with Genzyme and written into the GCVRZ rights agreement.

  • Reply to

    March 25th

    by grandmaster2986 Mar 25, 2014 1:43 PM
    js291955 js291955 Mar 26, 2014 2:43 AM Flag

    How can Sanofi report Lemtrada sales on March 25th for Q1 when Q1 ends on March 31st? After the end of Q1, it'll take another 2 weeks to summarize the data. Sales will be reported around April 15th, I guess.

  • Reply to

    Non standard options - what am I missing?

    by rjones47421 Mar 6, 2014 9:20 AM
    js291955 js291955 Mar 6, 2014 9:27 PM Flag

    Yes, they are the result of the reverse split and are difficult to trade. I talked to TD Ameritrade about them and even though they are difficult to trade, you can exercise them if you want to. For example, if you bought the non-standard $2 put (before the reverse split), you can exercise it and put your stock to the put seller for $20/share.

  • Less successful is Samsung’s take on the fingerprint-unlock system made popular by Apple with the iPhone 5S. Like the 5S, the S5’s home key features an integrated fingerprint scanner, which can be used to unlock the phone or authenticate purchases online (Samsung is partnering with PayPal to enable this feature, though it doesn’t validate purchases from the Google Play Store). Samsung’s version requires a vertical swipe over the home button to activate the scanner, and we found it to be quite unreliable and virtually impossible to activate when holding the phone in one hand. It can store up to three different digits, but it was very particular about the speed and orientation of the swiping motion used — if we weren’t doing a perfectly straight swipe down, it would refuse to unlock the phone.

    Sentiment: Strong Sell

JOY
64.34+0.66(+1.04%)9:36 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.